1.Hill, JO, Wyatt, HR, Reed, GW et al. (2003) Obesity and the environment: where do we go from here? Science 299, 853–855.
2.Arner, P, Andersson, DP, Bäckdahl, J et al. (2018) Weight gain and impaired glucose metabolism in Women are predicted by inefficient subcutaneous fat cell lipolysis. Cell Metab 28, 45–54. .
3.Afman, L & Müller, M (2012) Human nutrigenomics of gene regulation by dietary fatty acids. Prog Lipid Res 51, 63–70.
4.Crewe, C, An, YA & Scherer, PE (2017) The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest 127, 74–82.
5.Rosen, ED & Spiegelman, BM (2014) What we talk about when we talk about fat. Cell 156, 20–44.
6.Lafontan, M & Langin, D (2009) Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48, 275–297.
7.Arner, P & Langin, D (2014) Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance. Trends Endocrinol Metab 25, 255–262.
8.Rydén, M & Arner, P (2017) Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism. J Intern Med 282, 220–228.
9.Rydén, M & Arner, P (2017) Subcutaneous adipocyte lipolysis contributes to circulating lipid levels. Arterioscler Thromb Vasc Biol 37, 1782–1787.
10.Berg, AH & Scherer, PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96, 939–949.
11.Gesta, S, Tseng, Y-H & Kahn, CR (2007) Developmental origin of fat: tracking obesity to its source. Cell 131, 242–256.
12.Petrus, P, Mejhert, N, Corrales, P et al. (2018) Transforming growth factor-β3 regulates adipocyte number in subcutaneous white adipose tissue. Cell Rep 25, 551–560. .
13.Jeffery, E, Wing, A, Holtrup, B et al. (2016) The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metab 24, 142–150.
14.Jeffery, E, Church, CD, Holtrup, B et al. (2015) Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity. Nat Cell Biol 17, 376–385.
15.Hodson, L, Skeaff, CM & Fielding, B (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47, 348–380.
16.Seidelin, KN (1995) Fatty acid composition of adipose tissue in humans. Implications for the dietary fat-serum cholesterol-CHD issue. Prog Lipid Res 34, 4–6.
17.Nomenclature I-IC on B (1968) The nomenclature of lipids. Arch Biochem Biophys 123, 409–415.
18.Mozaffarian, D, Micha, R & Wallace, S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7, e1000252.
19.Summers, LKM, Fielding, B, Bradshaw, H et al. (2002) Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45, 369–377.
20.Bjermo, H & Iggman, D (2012) Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 95, 1003–1012.
21.Liu, X, Kris-Etherton, PM, West, SG et al. (2016) Effects of canola and high-oleic-acid canola oils on abdominal fat mass in individuals with central obesity. Obesity 24, 2261–2268.
22.Camargo, A, Rangel-Zúñiga, OA, Alcalá-Díaz, J et al. (2017) Dietary fat may modulate adipose tissue homeostasis through the processes of autophagy and apoptosis. Eur J Nutr 56, 1621–1628.
23.Rosqvist, F, Iggman, D, Kullberg, J et al. (2014) Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 63, 1–46.
24.Cardel, M, Lemas, DJ, Jackson, KH et al. (2015) Higher intake of PUFAs is associated with lower total and visceral adiposity and higher lean mass in a racially diverse sample of children. J Nutr 145, 2146–2152.
25.Hames, KC, Morgan-Bathke, M, Harteneck, DA et al. (2017) Very-long-chain ω-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial. Am J Clin Nutr 105, ajcn148114.
26.Perfilyev, A, Dahlman, I, Gillberg, L et al. (2017) Impact of polyunsaturated and saturated fat overfeeding on the DNA-methylation pattern in human adipose tissue: a randomized controlled trial. Am J Clin Nutr 105, 991–1000.
27.Huerta, AE, Prieto-Hontoria, PL, Sainz, N et al. (2016) Supplementation with -lipoic acid alone or in combination with eicosapentaenoic acid modulates the inflammatory status of healthy overweight or obese women consuming an energy-restricted diet. J Nutr 146, 889S–896S.
28.Mumme, K & Stonehouse, W (2015) Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J Acad Nutr Diet 115, 249–263.
29.Bueno, NB, de Melo, IV, Florêncio, TT et al. (2015) Dietary medium-chain triacylglycerols versus long-chain triacylglycerols for body composition in adults: systematic review and meta-analysis of randomized controlled trials. J Am Coll Nutr 34, 175–183.
30.Matualatupauw, JC, Bohl, M, Gregersen, S et al. (2017) Dietary medium-chain saturated fatty acids induce gene expression of energy metabolism-related pathways in adipose tissue of abdominally obese subjects. Int J Obes 41, 1348–1354.
31.Iggman, D, Ärnlöv, J, Cederholm, T et al. (2016) Association of adipose tissue fatty acids with cardiovascular and all-cause mortality in Elderly Men. JAMA Cardiol 1, 745.
32.Bork, CS, Jakobsen, MU, Lundbye-Christensen, S et al. (2016) Dietary intake and adipose tissue content of α-linolenic acid and risk of myocardial infarction: a Danish cohort study. Am J Clin Nutr 104, 41–48.
33.Garaulet, M, Pérez-Llamas, F, Pérez-Ayala, M et al. (2001) Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr 74, 585–591.
34.Petrus, P, Edholm, D, Rosqvist, F et al. (2017) Depot-specific differences in fatty acid composition and distinct associations with lipogenic gene expression in abdominal adipose tissue of obese women. Int J Obes 41, 1295–1298.
35.Papackova, Z & Cahova, M (2015) Fatty acid signaling: the new function of intracellular lipases. Int J Mol Sci 16, 3831–3855.
36.Berger, SL & Sassone-Corsi, P (2016) Metabolic signaling to chromatin. Cold Spring Harb Perspect Biol 8, 1210–1213.
37.Papsdorf, K & Brunet, A (2018) Linking lipid metabolism to chromatin regulation in aging. Trends Cell Biol 29, 97–116.
38.Etchegaray, JP & Mostoslavsky, R (2016) Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes. Mol Cell 62, 695–711.
39.Tontonoz, P, Hu, E & Spiegelman, BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 1147–1156.
40.Forman, BM, Tontonoz, P, Chen, J et al. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803–812.
41.Dahlman, I, Linder, K, Arvidsson Nordström, E et al. (2005) Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 81, 1275–1285.
42.Lancaster, GI, Langley, KG, Berglund, NA et al. (2018) Evidence that TLR4 is not a receptor for saturated fatty acids but mediates lipid-induced inflammation by reprogramming macrophage metabolism. Cell Metab 27, 1096–1110. .
43.Han, J, Hamilton, JA, Kirkland, JL et al. (2003) Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats. Obes Res 11, 734–744.
44.Bach, AC & Babayan, VK (1982) Medium-chain triglycerides: an update. Am J Clin Nutr 36, 950–962.
45.Bujalska, IJ, Kumar, S & Stewart, PM. (1997) Early reports does central obesity reflect “Cushing's disease of the omentum”? Lancet 349.
46.Wamil, M, Battle, JH, Turban, S et al. (2011) Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 60, 1158–1167.
47.Vara Prasad, SSS, Jeya Kumar, SS, Kumar, PU et al. (2010) Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue. Lipids Health Dis 9, 111.
48.Petrus, P, Rosqvist, F, Edholm, D et al. (2015) Saturated fatty acids in human visceral adipose tissue are associated with increased 11-β-hydroxysteroid-dehydrogenase type 1 expression. Lipids Health Dis 14, 42.